This complimentary program is geared toward U.S. companies expanding or starting business in China as well as U.S. private equity funds looking to expand their investment portfolios by acquiring equity interests in Chinese companies.
During this interactive session, panelists will discuss the common pitfalls of and practical strategies for doing business in China, including:
- Current trends impacting U.S. companies investing and doing business in China
- Special issues involved in acquiring equity interests in Chinese companies
- China’s foreign exchange control regulations and what they mean to U.S. companies in China
- Considerations on capital structure and available financing options for investments in China
- Managing employer-employee relationships in China
- Challenges of and opportunities arising from the current economic situations in the United States and China
Featured Speakers:
- H. Timothy Lopez, A.O. Smith, Associate General Counsel
- Kok-Chi Tsim, JPMorgan Chase, Managing Director and Senior Relationship Executive
- Z. Julie Lee, Foley International Business Transactions Partner
- Barry L. Grossman (Moderator), Foley Intellectual Property Of Counsel
Co-Sponsor:
People
Related Insights
23 April 2024
Article
The Rubber Meets the Road on State and Federal Vehicle Emissions Strategies
March and April have been busy months for vehicle emission regulation in the U.S. On March 20 and March 29 respectively, the U.S. Environmental Protection Agency issued a set of final emission rules setting stringent emission standards for all vehicle classes.
09 May 2024
Events
The Changing Hospital Landscape
Foley partner Larry Vernaglia, co-chair of the firm’s Providers of Health Care Services Area of Focus, is moderating a panel at the 2024 Convergence Forum titled “The Changing Hospital Landscape.”
23 April 2024
Article
U.S. Supreme Court Rules That “Pure Omissions” Are Not Actionable Under Rule 10b-5
On April 12, 2024, the United States Supreme Court delivered an important decision on the issue of whether a failure to make disclosure required under Item 303 of Regulation S-K can support a Rule 10b-5 claim, even in the absence of an otherwise-misleading statement.